Dr. Peter Graham Pantlin, MD

Dr. Pantlin practices at Ochsner Medical Center in New Orleans, Louisiana.

Dr. Pantlin's NPI, 1750842662, was assigned on March 26, 2019. Dr. Pantlin holds Louisiana license 330003.

Dr. Pantlin's primary practice is Ochsner Medical Center, at 1516 Jefferson Hwy, New Orleans, LA 70121 in Jefferson Parish. The practice phone is (504) 842-3000.

Dr. Pantlin's primary practice is Ochsner Medical Center in New Orleans, Louisiana.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pantlin practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Pantlin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Pantlin is licensed in Louisiana.

CMS data shows 12 Medicare services from Dr. Pantlin across 1 procedure code in 2024, for 12 Medicare patients. Medicare paid $1,588 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 12 Medicare patients who saw Dr. Pantlin in 2024. The largest group is under 65, with 0 patients. 75% of them have high blood pressure. Their average risk score is 3.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pantlin's median patient age at 72, with 35% women.

In 2024, Dr. Pantlin wrote 859 Medicare Part D claims for 198 patients. 74% of them were for generic drugs. CMS names the drug for 719 of them, across 21 drugs with 11 or more claims each, at $164,856 in total drug cost. In 2023, CMS named 313 claims across 15 drugs.

Dmand AI links 6 papers to Dr. Pantlin, published from 2020 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Ventricular Function, Left, Anti-Arrhythmia Agents and Arrhythmias, Cardiac. Dr. Pantlin has published most often in J Cardiovasc Electrophysiol. Dr. Pantlin's most frequent co-authors are Daniel Patrick Morin, MD, MPH, Robert M. Bober, MD and Sammy Khatib, MD.

CMS Open Payments shows 234 general payments to Dr. Pantlin from 23 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 71% of the total. Boston Scientific Corporation paid the most, $4,391.